BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 27174787)

  • 1. CD169 identifies an anti-tumour macrophage subpopulation in human hepatocellular carcinoma.
    Zhang Y; Li JQ; Jiang ZZ; Li L; Wu Y; Zheng L
    J Pathol; 2016 Jun; 239(2):231-41. PubMed ID: 27174787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD169(+) macrophages mediate pathological formation of woven bone in skeletal lesions of prostate cancer.
    Wu AC; He Y; Broomfield A; Paatan NJ; Harrington BS; Tseng HW; Beaven EA; Kiernan DM; Swindle P; Clubb AB; Levesque JP; Winkler IG; Ling MT; Srinivasan B; Hooper JD; Pettit AR
    J Pathol; 2016 Jun; 239(2):218-30. PubMed ID: 27174786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD169-positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma.
    Ohnishi K; Komohara Y; Saito Y; Miyamoto Y; Watanabe M; Baba H; Takeya M
    Cancer Sci; 2013 Sep; 104(9):1237-44. PubMed ID: 23734742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer.
    Shiota T; Miyasato Y; Ohnishi K; Yamamoto-Ibusuki M; Yamamoto Y; Iwase H; Takeya M; Komohara Y
    PLoS One; 2016; 11(11):e0166680. PubMed ID: 27861544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of CD169-positive lymph node sinus macrophages in patients with endometrial carcinoma.
    Ohnishi K; Yamaguchi M; Erdenebaatar C; Saito F; Tashiro H; Katabuchi H; Takeya M; Komohara Y
    Cancer Sci; 2016 Jun; 107(6):846-52. PubMed ID: 26991548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional CD169 on Macrophages Mediates Interaction with Dendritic Cells for CD8
    van Dinther D; Veninga H; Iborra S; Borg EGF; Hoogterp L; Olesek K; Beijer MR; Schetters STT; Kalay H; Garcia-Vallejo JJ; Franken KL; Cham LB; Lang KS; van Kooyk Y; Sancho D; Crocker PR; den Haan JMM
    Cell Rep; 2018 Feb; 22(6):1484-1495. PubMed ID: 29425504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct patterns and prognostic values of tumor-infiltrating macrophages in hepatocellular carcinoma and gastric cancer.
    Li JQ; Yu XJ; Wang YC; Huang LY; Liu CQ; Zheng L; Fang YJ; Xu J
    J Transl Med; 2017 Feb; 15(1):37. PubMed ID: 28202073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Significance of CD169+ Lymph Node Sinus Macrophages in Patients with Malignant Melanoma.
    Saito Y; Ohnishi K; Miyashita A; Nakahara S; Fujiwara Y; Horlad H; Motoshima T; Fukushima S; Jinnin M; Ihn H; Takeya M; Komohara Y
    Cancer Immunol Res; 2015 Dec; 3(12):1356-63. PubMed ID: 26297710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
    Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
    Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD169-positive sinus macrophages in the lymph nodes determine bladder cancer prognosis.
    Asano T; Ohnishi K; Shiota T; Motoshima T; Sugiyama Y; Yatsuda J; Kamba T; Ishizaka K; Komohara Y
    Cancer Sci; 2018 May; 109(5):1723-1730. PubMed ID: 29520898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer cells promote CD169
    Jing W; Guo X; Wang G; Bi Y; Han L; Zhu Q; Qiu C; Tanaka M; Zhao Y
    Int Immunopharmacol; 2020 Jan; 78():106012. PubMed ID: 31865052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Higher Frequency of CD14+ CD169+ Monocytes/Macrophages in Patients with Colorectal Cancer.
    Li C; Luo X; Lin Y; Tang X; Ling L; Wang L; Jiang Y
    PLoS One; 2015; 10(10):e0141817. PubMed ID: 26509874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Met identifies a population of matrix metalloproteinase 9-producing monocytes in peritumoural stroma of hepatocellular carcinoma.
    Zhao L; Wu Y; Xie XD; Chu YF; Li JQ; Zheng L
    J Pathol; 2015 Nov; 237(3):319-29. PubMed ID: 26108200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of cytotoxic and natural killer T-cell system in patients with hepatocellular carcinoma and cirrhosis.
    Marafin C; Rinaldi M; Angonese C; De Franchis G; Plebani M; Naccarato R; Farinati F
    Ital J Gastroenterol; 1996 Dec; 28(9):493-8. PubMed ID: 9131393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
    Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
    Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Delivery of Antigen to Activated CD169
    Edgar LJ; Kawasaki N; Nycholat CM; Paulson JC
    Cell Chem Biol; 2019 Jan; 26(1):131-136.e4. PubMed ID: 30393066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a FOXP3(+)CD3(+)CD56(+) population with immunosuppressive function in cancer tissues of human hepatocellular carcinoma.
    Li X; Peng J; Pang Y; Yu S; Yu X; Chen P; Wang W; Han W; Zhang J; Yin Y; Zhang Y
    Sci Rep; 2015 Oct; 5():14757. PubMed ID: 26437631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD68(+)HLA-DR(+) M1-like macrophages promote motility of HCC cells via NF-κB/FAK pathway.
    Wang H; Wang X; Li X; Fan Y; Li G; Guo C; Zhu F; Zhang L; Shi Y
    Cancer Lett; 2014 Apr; 345(1):91-9. PubMed ID: 24333724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD169 Defines Activated CD14
    Affandi AJ; Olesek K; Grabowska J; Nijen Twilhaar MK; Rodríguez E; Saris A; Zwart ES; Nossent EJ; Kalay H; de Kok M; Kazemier G; Stöckl J; van den Eertwegh AJM; de Gruijl TD; Garcia-Vallejo JJ; Storm G; van Kooyk Y; den Haan JMM
    Front Immunol; 2021; 12():697840. PubMed ID: 34394090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-17-educated monocytes suppress cytotoxic T-cell function through B7-H1 in hepatocellular carcinoma patients.
    Zhao Q; Xiao X; Wu Y; Wei Y; Zhu LY; Zhou J; Kuang DM
    Eur J Immunol; 2011 Aug; 41(8):2314-22. PubMed ID: 21674477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.